1. Home
  2. XPER vs ABEO Comparison

XPER vs ABEO Comparison

Compare XPER & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xperi Inc.

XPER

Xperi Inc.

HOLD

Current Price

$6.48

Market Cap

272.9M

Sector

Technology

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.50

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPER
ABEO
Founded
1990
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.9M
280.2M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
XPER
ABEO
Price
$6.48
$5.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$11.67
$20.00
AVG Volume (30 Days)
212.4K
1.2M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
165.16
EPS
N/A
1.01
Revenue
$448,105,000.00
$2,998,000.00
Revenue This Year
$4.03
$1,024.31
Revenue Next Year
$8.11
$145.42
P/E Ratio
N/A
$5.33
Revenue Growth
N/A
258.18
52 Week Low
$5.07
$4.00
52 Week High
$8.24
$7.54

Technical Indicators

Market Signals
Indicator
XPER
ABEO
Relative Strength Index (RSI) 72.09 67.61
Support Level $6.34 $5.24
Resistance Level $6.49 $5.62
Average True Range (ATR) 0.19 0.23
MACD 0.08 0.11
Stochastic Oscillator 86.36 95.82

Price Performance

Historical Comparison
XPER
ABEO

About XPER Xperi Inc.

Xperi Inc is a media and entertainment technology company. Its technologies are integrated into consumer devices, connected cars, and a variety of media platforms globally, enabling audiences to connect with entertainment content in a more intelligent, immersive, and personal way. As its audiences engage with content on the platform, the company operates a cross-screen advertising solution that enables brands to reach millions of engaged consumers across rapidly expanding digital entertainment ecosystem. It operates in one reportable business segment and group its revenue into four categories: Pay-TV, Consumer Electronics, Connected Car and Media Platform. Geographically it operates in U.S. and Canada, Asia Pacific, Europe, Middle East and Africa, and Other countries.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: